Costs and effects of enalapril therapy in patients with symptomatic heart failure: An economic analysis of the studies of left ventricular dysfunction (SOLVD) treatment trial
Authors:
- John CookJCJohn Cook
- Bruce KinosianBKBruce Kinosian
- Bertram PittBPBertram Pitt
- Martial G. BourassaMBMartial G. Bourassa
- Hubert PouleurHPHubert Pouleur
- William GerthWGWilliam Gerth
- 1 December 1995
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 1 (5) , 371-380
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Decision Analytic Modeling: Some Uses in the Evaluation of New PharmaceuticalsDrug Information Journal, 1994
- Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failureArchives of internal medicine (1960), 1994
- Epidemiology of heart failure in the United StatesAmerican Heart Journal, 1993
- Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.Circulation, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalenceArchives of internal medicine (1960), 1990
- Physician utilization of laboratory procedures to monitor outpatients with congestive heart failureArchives of internal medicine (1960), 1989
- Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failureJAMA, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987